Product NDC: | 40032-360 |
Proprietary Name: | Phenelzine Sulfate |
Non Proprietary Name: | Phenelzine Sulfate |
Active Ingredient(s): | 15 mg/1 & nbsp; Phenelzine Sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 40032-360 |
Labeler Name: | Novel Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200181 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110214 |
Package NDC: | 40032-360-21 |
Package Description: | 60 TABLET in 1 BOTTLE (40032-360-21) |
NDC Code | 40032-360-21 |
Proprietary Name | Phenelzine Sulfate |
Package Description | 60 TABLET in 1 BOTTLE (40032-360-21) |
Product NDC | 40032-360 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Phenelzine Sulfate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110214 |
Marketing Category Name | ANDA |
Labeler Name | Novel Laboratories, Inc. |
Substance Name | PHENELZINE SULFATE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |